Drug Trial Radar · NCT02345226
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
Last checked: Nov 20, 2026Latest source record: Jan 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
881
Actual
Start
Jan 26, 2015
Primary completion
Jun 29, 2016
Study completion Jan 2, 2019
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Jan 26, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the non-inferiority of switching to emtricitabine/rilpivirine/tenofovir alafenamide (FTC/RPV/TAF) fixed dose combination (FDC) as compared to continuing the non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen of efavirenz /FTC/tenofovir disoproxil fumarate (EFV/FTC/TDF) FDC in virologically-suppressed HIV-1 infected participants.
Conditions
- HIV-1 Infection
Interventions
FTC/RPV/TAFDrug
200/25/25 mg FDC tablets administered orally once daily
EFV/FTC/TDF PlaceboDrug
Tablets administered orally once daily
EFV/FTC/TDFDrug
600/200/300 mg FDC tablets administered orally once daily
FTC/RPV/TAF PlaceboDrug
Tablets administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 48 as Defined by the US FDA-defined Snapshot AlgorithmTime frame: Week 48
Locations
117 sites in 9 countries. Site status is shown where the registry gives one.
Maricopa Integrated Health System
Phoenix, Arizona
Spectrum Medical Group
Phoenix, Arizona
AHF Research Center
Beverly Hills, California
Pacific Oaks Medical Group
Beverly Hills, California
Long Beach Education and Research Consultants
Long Beach, California
Kaiser Permanente
Los Angeles, California
Southern California Men's Medical Group
Los Angeles, California
Tarrant County ID Associates
Los Angeles, California
Kaiser Permanente
Sacramento, California
University of California-UC Davis
Sacramento, California
La Playa Medical Group and Clinical Research
San Diego, California
Kaiser Permanente
San Francisco, California
Optimus Medical
San Francisco, California
Kaiser Permanente
San Leandro, California
Los Angeles BioMedical Institute at Harbor-UCLA Medical Center
Torrance, California
University of Colorado
Aurora, Colorado
Apex Research Institute
Denver, Colorado
Yale University School of Medicine
New Haven, Connecticut
World Health Clinicians' CIRCLE CARE Center
Norwalk, Connecticut
Capital Medical Associates, P.C.
Washington D.C., District of Columbia
Medical Faculty Associates, Inc.
Washington D.C., District of Columbia
Whitman Walker Clinic
Washington D.C., District of Columbia
Gary Richmond, MD, PA, Inc.
Fort Lauderdale, Florida
Therafirst Medical Centers
Fort Lauderdale, Florida
Midway Immunology & Research Center, LLC
Ft. Pierce, Florida
AIDS Healthcare Foundation
Miami, Florida
University of Miami
Miami, Florida
AIDS Healthcare Foundation
Miami Beach, Florida
Orlando Immunology Center
Orlando, Florida
Infectious Diseases Associates of NW Florida, P.A.
Pensacola, Florida
Hillsborough County Health Dept.
Tampa, Florida
Infectious Disease Research Institute Inc.
Tampa, Florida
St. Joseph's Comprehensive Research Institute
Tampa, Florida
AIDS Research & Treatment Center of the Treasure Coast
Vero Beach, Florida
Triple O Research Institute, P.A.
West Palm Beach, Florida
Rowan Tree Medical PA
Wilton Manors, Florida
AIDS Research Consortium of Atlanta
Atlanta, Georgia
Atlanta ID Group
Atlanta, Georgia
Infectious Disease Specialists of Atlanta
Decatur, Georgia
Mercer University School of Medicine
Macon, Georgia
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.